OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Practical management of patients on Janus kinase inhibitor (JAKi) therapy: Practical fact sheets drawn up by the Rheumatism and Inflammation Club (CRI), a group endorsed by the French Society for Rheumatology (SFR)
Christophe Richez, Jacques Morel, Divi Cornec, et al.
Joint Bone Spine (2019) Vol. 86, pp. eS2-eS103
Closed Access | Times Cited: 11
Christophe Richez, Jacques Morel, Divi Cornec, et al.
Joint Bone Spine (2019) Vol. 86, pp. eS2-eS103
Closed Access | Times Cited: 11
Showing 11 citing articles:
Predictors for clinical effectiveness of baricitinib in rheumatoid arthritis patients in routine clinical practice: data from a Japanese multicenter registry
Nobunori Takahashi, Shuji Asai, Tomonori Kobayakawa, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 25
Nobunori Takahashi, Shuji Asai, Tomonori Kobayakawa, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 25
2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis
Bruno Fautrel, Joanna Kedra, Pierre‐Antoine Juge, et al.
Joint Bone Spine (2024) Vol. 91, Iss. 6, pp. 105790-105790
Closed Access | Times Cited: 3
Bruno Fautrel, Joanna Kedra, Pierre‐Antoine Juge, et al.
Joint Bone Spine (2024) Vol. 91, Iss. 6, pp. 105790-105790
Closed Access | Times Cited: 3
Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report
M Fernandez-Sanchez, Hugo Ribes‐Artero, Eva Romá‐Sánchez, et al.
Birth Defects Research (2021) Vol. 113, Iss. 17, pp. 1275-1279
Closed Access | Times Cited: 13
M Fernandez-Sanchez, Hugo Ribes‐Artero, Eva Romá‐Sánchez, et al.
Birth Defects Research (2021) Vol. 113, Iss. 17, pp. 1275-1279
Closed Access | Times Cited: 13
Screening the Extract of Laportea bulbifera (Sieb. et Zucc.) Wedd. Based on Active Component Content, Its Antioxidant Capacity and Exploration of Hepatoprotective Activity in Rats
Jiaxin Feng, Yue Sun, Z.X. Wei, et al.
Molecules (2023) Vol. 28, Iss. 17, pp. 6256-6256
Open Access | Times Cited: 5
Jiaxin Feng, Yue Sun, Z.X. Wei, et al.
Molecules (2023) Vol. 28, Iss. 17, pp. 6256-6256
Open Access | Times Cited: 5
Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations
Melinda Gooderham, Marjolein de Bruin‐Weller, Stephan Weidinger, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 8, pp. 2285-2296
Open Access | Times Cited: 1
Melinda Gooderham, Marjolein de Bruin‐Weller, Stephan Weidinger, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 8, pp. 2285-2296
Open Access | Times Cited: 1
Actualisation 2024 des recommandations de la Société Française de Rhumatologie pour le diagnostic et la prise en charge des personnes souffrant de polyarthrite rhumatoïde
Bruno Fautrel, Joanna Kedra, Pierre‐Antoine Juge, et al.
Revue du Rhumatisme (2024) Vol. 91, Iss. 6, pp. 663-693
Open Access | Times Cited: 1
Bruno Fautrel, Joanna Kedra, Pierre‐Antoine Juge, et al.
Revue du Rhumatisme (2024) Vol. 91, Iss. 6, pp. 663-693
Open Access | Times Cited: 1
Evaluating filgotinib for the treatment of rheumatoid arthritis
Christophe Richez, Marie‐Elise Truchetet
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 18, pp. 2435-2444
Closed Access | Times Cited: 7
Christophe Richez, Marie‐Elise Truchetet
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 18, pp. 2435-2444
Closed Access | Times Cited: 7
Patients’ safety skills assessment with biologics and JAK inhibitors: Update of the BioSecure questionnaire
Catherine Beauvais, Véronique Gaud-Listrat, Jérémie Sellam, et al.
Joint Bone Spine (2021) Vol. 88, Iss. 5, pp. 105215-105215
Closed Access | Times Cited: 6
Catherine Beauvais, Véronique Gaud-Listrat, Jérémie Sellam, et al.
Joint Bone Spine (2021) Vol. 88, Iss. 5, pp. 105215-105215
Closed Access | Times Cited: 6
Development and real-life use assessment of a self-management smartphone application for patients with inflammatory arthritis. A user-centred step-by-step approach
Catherine Beauvais, Thao Pham, Guillaume Montagu, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0272235-e0272235
Open Access | Times Cited: 4
Catherine Beauvais, Thao Pham, Guillaume Montagu, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0272235-e0272235
Open Access | Times Cited: 4
What value do JAK inhibitors have in treating rheumatoid arthritis?
Christophe Richez, Marie‐Elise Truchetet
Expert Opinion on Pharmacotherapy (2020) Vol. 21, Iss. 15, pp. 1789-1792
Open Access | Times Cited: 4
Christophe Richez, Marie‐Elise Truchetet
Expert Opinion on Pharmacotherapy (2020) Vol. 21, Iss. 15, pp. 1789-1792
Open Access | Times Cited: 4
Évaluation des compétences de sécurité des patients vis à vis des biothérapies et inhibiteurs de JAK : actualisation du questionnaire BioSecure
Catherine Beauvais, Véronique Gaud-Listrat, Jérémie Sellam, et al.
Revue du Rhumatisme (2021) Vol. 89, Iss. 2, pp. 187-189
Closed Access
Catherine Beauvais, Véronique Gaud-Listrat, Jérémie Sellam, et al.
Revue du Rhumatisme (2021) Vol. 89, Iss. 2, pp. 187-189
Closed Access
